Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
RGC Resources
RGCO
$227M
| $903K | ﹤0.01% |
45,033
-700
| -2% | -$14.5K |
|
2552
Rockwell Medical
RMTI
$29.6M
| $902K | ﹤0.01% |
44,235
+32,768
| +286% | +$956K |
|
|
ELEV
2553
DELISTED
Elevation Oncology
ELEV
| $902K | ﹤0.01% |
1,603,309
-182,673
| -10% | -$108K |
|
2554
Metropolitan Bank Holding Corp
MCB
$1.16B
| $899K | ﹤0.01% |
15,400
-17,100
| -53% | -$1.03M |
|
2555
Horace Mann Educators
HMN
$2.11B
| $898K | ﹤0.01% |
22,900
+1,500
| +7% | +$58.6K |
|
2556
Plumas Bancorp
PLBC
$435M
| $898K | ﹤0.01% |
18,999
+5,699
| +43% | +$256K |
|
2557
Atara Biotherapeutics
ATRA
$74.7M
| $894K | ﹤0.01% |
67,140
-594
| -0.9% | -$6.26K |
|
|
RERE
2558
ATRenew
RERE
$997M
| $893K | ﹤0.01% |
309,900
-203,137
| -40% | -$565K |
|
2559
WidePoint Corp
WYY
$92.7M
| $892K | ﹤0.01% |
184,400
+101,176
| +122% | +$437K |
|
2560
Wendy's
WEN
$1.63B
| $886K | ﹤0.01% |
+54,352
| New | +$992K |
|
|
EEX
2561
DELISTED
Emerald Holding
EEX
| $886K | ﹤0.01% |
183,757
-22,000
| -11% | -$101K |
|
2562
Adicet Bio
ACET
$77M
| $882K | ﹤0.01% |
57,281
-19,694
| -26% | -$372K |
|
|
SELF
2563
Global Self Storage
SELF
$59.6M
| $881K | ﹤0.01% |
165,375
-8,900
| -5% | -$45.5K |
|
2564
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.13B
| $881K | ﹤0.01% |
+10,100
| New | +$902K |
|
2565
Agilon Health
AGL
$1.64B
| $880K | ﹤0.01% |
18,532
+11,268
| +155% | +$681K |
|
2566
Smart Sand
SND
$218M
| $879K | ﹤0.01% |
390,679
+183,779
| +89% | +$410K |
|
2567
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.8B
| $874K | ﹤0.01% |
7,000
-16,500
| -70% | -$2.13M |
|
2568
Algoma Steel
ASTL
$452M
| $874K | ﹤0.01% |
89,374
+8,974
| +11% | +$92.6K |
|
2569
iShares Global Tech ETF
IXN
$9.41B
| $873K | ﹤0.01% |
+10,300
| New | +$865K |
|
2570
Fidelity MSCI Financials Index ETF
FNCL
$2.43B
| $872K | ﹤0.01% |
12,700
+3,400
| +37% | +$234K |
|
2571
Huntsman Corp
HUN
$1.79B
| $871K | ﹤0.01% |
48,299
-199,201
| -80% | -$4.15M |
|
|
ICAD
2572
DELISTED
iCAD Inc
ICAD
| $870K | ﹤0.01% |
475,593
-125,697
| -21% | -$223K |
|
2573
INmune Bio
INMB
$59.4M
| $868K | ﹤0.01% |
185,800
+78,600
| +73% | +$410K |
|
2574
Bread Financial
BFH
$4.57B
| $867K | ﹤0.01% |
14,200
-84,442
| -86% | -$4.77M |
|
|
MRSN
2575
DELISTED
Mersana Therapeutics
MRSN
| $867K | ﹤0.01% |
24,251
+4,542
| +23% | +$235K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.